The key objective of the study was to determine the single and multiple does toxicity and efficay of Bismuth-213 labeled PAI2 based targeted alpha therapy by selectively targeting uPA and uPAR in regressing prostate cancer in a nude mouse model.
RIZVI S.M.A.;
LI Y.;
SONG E.;
QU C.F.;
RAJA C.;
MORGENSTERN Alfred;
APOSTOLIDIS Christos;
ALLEN B.J.;
2006-11-03
LANDES BIOSCIENCE
JRC35141
https://publications.jrc.ec.europa.eu/repository/handle/JRC35141,
| Name | Country | City | Type |
|---|
This document is only visible at the Commission level.
You are not authorized to publish or distribute it outside the European Commission.
This is a public document. You can share this publication.
Datasets
| ID | Title | Public URL |
|---|
Dataset collections
| ID | Acronym | Title | Public URL |
|---|
Scripts / source codes
| Description | Public URL |
|---|
Additional supporting files
| File name | Description | File type |
|---|